Guides
How to Taper Off a GLP-1 vs. Stopping Cold Turkey (2026)

Whether you're choosing to stop or your access is ending, one question comes up first: do you taper the dose down, or just stop? There's no single official answer, but the way you come off is worth thinking through with a provider rather than leaving to a lapsed refill. Our full guide to staying off without the rebound covers the whole window; this is the stopping decision itself.
Why how you stop matters
GLP-1 medication works by quieting the appetite signals that drive eating. Stop abruptly and those signals can return all at once; a gradual step-down is intended to give appetite and eating habits time to adjust rather than snapping back. That's the reasoning behind a taper — but the evidence base for a specific schedule is thin, which is exactly why it's a provider conversation.
There's no single official taper
Practice varies. Some providers step the dose down over weeks; others stop at a planned point once a patient is stable. Some patients move to a lower maintenance dose instead of stopping entirely — the middle path we cover in tirzepatide maintenance dosing. What matters is that the plan is made with a provider who knows your history, not triggered by a program shutting off.
Planning a wind-down around a forced end
If cost or coverage is ending your access, talk to a licensed provider before you simply run out — a short, planned taper tends to go better than an abrupt stop. And check your options first: our coverage guide covers appeals, manufacturer programs, and HSA/FSA, any of which might keep continuation on the table.
What to expect either way
Be clear-eyed about the biology: in trials, people who stopped semaglutide regained roughly two-thirds of the lost weight within a year, and a 2026 meta-analysis puts the figure near 60% across studies. That's not a verdict on you — it's the appetite biology returning, and it's what makes a maintenance plan the real work of coming off. See what happens when you stop tirzepatide and stopping Ozempic for the first ninety days.
Keep reading
This article is for informational purposes only and does not constitute medical advice. Compounded tirzepatide is not FDA-approved. A licensed provider determines whether treatment is appropriate for you. Read how we source and review content and the references behind the clinical figures used on this site.